Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/31/02 → 4/30/05 |
Phase 3 Double-Masked , Placebo -Controlled Study of Alicaforsen (ISIS 2302), an Antisense Inhibitor of ICAM-1, for the Treatment of Patients with Active Crohn's Disease
- De Villiers, Willem (PI)